Chapter 18 Responding to doubts, slapping her face on the spot

"Mr. Wei, please answer me, is this data true or false?"

This sentence exploded in everyone's ears like a thunder.

Everyone looked at Dr. Schmitz in shock and was stunned for a while.

To actually openly question the authenticity of the clinical trial report at the press conference is a door-to-door provocation.

Good guy, you can't refute the other party's curative effect, so you just draw your salary from the bottom of the pot and suspect that the other party is fake.

For the sake of the domestic anti-cancer drug market, is this going to be unscrupulous and directly tear your face?

Representatives of domestic pharmaceutical companies were all ashamed and annoyed. Originally, they also felt that the effect of the new anti-cancer drug was really good, and they couldn't believe it.

However, Dr. Schmitz's arrogant questioning, that kind of contempt and suspicion of domestic pharmaceutical companies, as if a huge slap slapped on the faces of all of them, instantly aroused their hatred of the same enemy.

Even Mr. Wu of Xinmei has an ugly face at this moment, and he is very angry in his heart. He has seen this kind of arrogance and prejudice a lot when dealing with foreign giants. Seeing Sanqing being questioned at this moment, I felt a little empathy, as if every question was torturing my soul.

He clenched his fists and said inwardly, "Little bastard, don't lie. If you are exposed by a foreigner and embarrass the domestic pharmaceutical companies, then I will never let you go."

The faces of the media at this time were also very ugly. At the beginning, they were ecstatic in their hearts, feeling that they had caught an explosive news.

But they quickly realized that they were all irritated by Schmitz's questioning.

Why, Huaxia's pharmaceutical companies can't produce effective anticancer drugs, can they?

Why do you suspect that Sanqing’s data is falsified?

Other international pharmaceutical giants showed gloating smiles.

Although they were all shocked by Schmitz's direct questioning, it did speak their minds.

Originally, they were skeptical when they came here, but after seeing the clinical data, they just didn't believe it.

So many pharmaceutical companies around the world invest tens of billions in research and development every year, but it turns out that such a little-known Chinese pharmaceutical company has developed this magic drug.

It's just unbelievable, it's absolutely fake.

They thought so in their hearts, but after all, there is no direct competition for the time being, and there is no need to tear their faces like Merck.

So the representative of Roche Pharmaceuticals nodded in agreement.

Everyone else had curious expressions on their faces.

Therefore, everyone looked at Wei Kang with great anticipation, to see how he would respond to this question.

Naturally, Wei Kang was not stage frightened at all.

He sneered and asked sharply.

"Dr. Schmitz, I would like to ask, is Merck's drug research and development capability the number one in the world? Can it represent the highest strength in the global pharmaceutical industry?"

"As far as I know, Merck is not the No. 1 pharmaceutical company in the world. Moreover, your strength in anticancer drugs is not strong. In terms of drug research and development, it is really lackluster."

What Wei Kang said made Dr. Schmitz a little annoyed.

"Are you doubting my authority?"

"Young man, Merck is indeed not the number one pharmaceutical company in the world, and it is true that there is only one key anti-cancer product, Keyradar. But we have been unremittingly developing anti-cancer drugs."

"We have worked in the field of anti-cancer drugs for decades, and the annual R\u0026D funds invested are beyond your imagination. Last year, Merck's oncology business revenue was 15.8 billion US dollars, but our R\u0026D investment last year was also the highest among all pharmaceutical giants. It reached $13.5 billion."

"I think the tens of billions of research and development investment every year can explain something."

"The funds we have invested are incomparable to all the pharmaceutical companies in your country combined, and even far exceed the market value of many of your pharmaceutical companies."

"Mr. Wei, I would like to ask, how much money does your company invest in research and development every year?"

Wei Kang nodded and said: "You are also reasonable, so you mean that whoever spends more money in research and development of drugs will be able to succeed? Whoever spends less money will definitely not be successful?"

"I remember news reports that Merck spends billions of dollars every year to purchase new drug formulations from other laboratories, and even acquires many other small pharmaceutical companies. Is this true?"

"Since you are so rich and have invested tens of billions of dollars, why haven't you developed the second Keyradar or other targeted drugs?"

"So rich, why haven't you developed new drugs that small pharmaceutical companies can develop?"

Dr. Schmitz was suddenly at a loss for words, and he couldn't think of words to refute for a while.

After all, in this line of work, we only look at the results, not the words.

No matter how much you say, how much money you invest, but if there is no result, it just won't work.

This young man is really eloquent and difficult to deal with!

But he won't back down, he must push the other party into a dead corner so that he can't stand up.

After all, Merck’s cancer business revenue accounts for 40% of its pharmaceutical business revenue, and more than 95% of its revenue comes from Keyreda. It can be said that Merck’s tumor business revenue is tied to Keyreda, which is extremely risky. It would be a nightmare for the company if a broad-spectrum anti-tumor drug with miraculous efficacy emerges and completely replaces Keyradar.

In China's anti-cancer drug market, Merck's pharmaceutical business revenue in China was 3.534 billion US dollars, a year-on-year increase of 13%, which is Merck's best-performing market in the world.

The scale of the global tumor market has reached US$150 billion, and has maintained a rapid growth rate of 15% in the past five years. It is relatively low and is still in the early stage of development, with broad room for future development.

Every giant pharmaceutical company will not give up the huge fat of the Chinese market with unlimited potential.

So Dr. Schmitz pulled out his trump card.

"Mr. Wei, clinical trial data can be falsified, how do you prove that these data are true?"

Wei Kang smiled slightly, hehe, I was just waiting for your words.

Do you think I will come to this press conference unprepared to face you bunch of arrogant foreign devils?

He said decisively: "This clinical data report is absolutely true, I can guarantee it."

"Besides, I have evidence here."

He turned on the computer and played new data on the projection screen.

"This is the case of some patients in the First People's Hospital of Kunming City. You can clearly see the comparison before and after taking our new drug. This is the blood test report, here is the CT and color Doppler ultrasound, and some patients' operation and treatment information. And the patient's before and after illness photos."

"We have obtained the consent of a total of 100 patients, and they are willing to share their cases as evidence, so that everyone can see how miraculous the effect of this drug is."

"Each of you can come to me to view the medical records of these 100 patients, but for the sake of patient privacy, you can only view them here, not take them out."

"For any drug, all paper data is pale. Only the patient's curative effect is the most intuitive and real evidence. Only the patient's recovery can prove the success of this drug."

"Then, please take a good look at how successful our new anti-cancer drug is!"

"If you are still prejudiced and unwilling to believe the real data and cases I provided. Then, you can only slap you in the face after this drug is on the market."

"In this regard, I will wait and see!"

At this time, a female doctor in a white coat suddenly stood up from the audience and said loudly: "I am an oncologist at the First People's Hospital of Kunming City, and I can guarantee the authenticity of these cases."

Immediately, several doctors in white coats stood up next to her, old and young, all her colleagues, all nodded in unison, solemnly declared their identities, and made a promise.

Dr. Schmitz's face was flushed, he hesitated for a while, and then said: "Then the side effects in your report are so small, this is absolutely impossible!"

Wei Kang snorted coldly, looked at him and said, "Oh, your Corida has a lot of side effects, so you think the anti-cancer drug we developed should also have a lot of side effects?"

He suddenly smiled: "Let me think about the side effects of Keyreda?"

"Well, it seems that there are indeed many side effects," Wei Kang laughed, and recited a passage that he had prepared for a long time.

"Major adverse reactions of Coreta include edema, dizziness, diarrhea, nausea, dysesthesia, dyspnea, myalgia, cognitive impairment, cough, vomiting, fever, arthralgia, and visual abnormalities."

"The most serious adverse reactions are congestive heart failure, central nervous system reactions (cognitive impairment, anxiety, depression or even suicidal thoughts, dizziness or loss of balance, insomnia or hypersomnia), fractures, liver toxicity, hyperuricemia , QT prolongation, and visual abnormalities."

After reciting it, he sneered and said, "Does your medicine save people or kill people?"

"Dr. Schmitz, what you can't do doesn't mean we can't do it."

"After so many years of development and revitalization, our country's pharmaceutical industry has become very developed. I dare not say it is better than the top international pharmaceutical companies, but it has reached the international leading level in some aspects."

"On this point, President Wu of Xinmei Pharmaceutical Group should have a say."

"As far as I know, Xinmei Group has recently developed an anticancer needle for lymphoma, which can be cured in two months without any serious side effects. Mr. Wu, am I right?"

Mr. Wu was sitting down listening intently, when he was suddenly called by Wei Kang, he couldn't help but be taken aback.

When he reacted, he was also very proud. He raised his chest and said, "Yes, Xinmei's research and development strength in anti-cancer targeted drugs is also very strong. At least targeted drugs are no worse than Merck. Haha. "

He looked at Pfizer's Andre and said with a smile: "And Xinmei has recently cooperated with Pfizer to create an anti-cancer targeted drug matrix. Mr. Andre, I'm right."

Andre hesitated for a while, then nodded slightly.

Dr. Schmitz turned pale and sat down without saying a word.

The media reporters were stunned. Why are the people from these pharmaceutical companies silent?

Could it be that the clinical trial report is true, and what Wei Kang said has been confirmed?

They immediately became excited.

Wow, big news, Sanqing Pharmaceutical faced the provocation of international pharmaceutical giants at the new drug launch conference, and slapped it on the spot!

Faced with doubts from the global authority on oncology, Mr. Wei Kangwei made the other party speechless with a lot of rhetoric!

At the same time, he resolutely showed the evidence, defended his reputation, and greatly boosted the prestige of my country's pharmaceutical industry!

If this is reported, it will be another piece of shocking headlines and boiling patriotic news.

Sanqing's new anti-cancer drug is really surprising. This new anti-cancer drug has 100% curative effect and zero side effects.

It will surely replace the anti-cancer drugs of other pharmaceutical companies and become the most popular and legendary miracle drug in the next few decades.